Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dendreon Surges After Cancer Drug Gets European Backing
Bloomberg
Friday, June 28, 2013 - 10:33am
tags:
prostate cancer, Europe, Dendreon, Provenge
Astellas/Vical Start TransVax Phase III Study
Yahoo/Zacks
Friday, June 28, 2013 - 10:30am
tags:
CMV, cytomegalovirus, TransVax, clinical trials, Astellas, vaccines, Vical
For Allergan Shareholders, Will it Be Dry Eyes or Tears of Joy?
Motley Fool
Friday, June 28, 2013 - 10:26am
tags:
Allergan, Restasis, dry eye disease
Roche inks cancer pact with UK's Immunocore
Pharma Times, UK
Friday, June 28, 2013 - 10:25am
tags:
Roche, Immunocore, cancer
Fish-Oil Pills Lure Drugmakers Even as Benefits Unproven
Bloomberg
Friday, June 28, 2013 - 10:23am
tags:
Amarin, fish oil, AstraZeneca, GSK
Biosimilar versions of Remicade given EU green light
Reuters
Friday, June 28, 2013 - 10:15am
tags:
Remicade, biosimilars, Europe, Celltrion, Remsima, Hospira, Inflectra, rheumatoid arthritis
Eli Lilly Hopes To End Novo Nordisk's Stranglehold On The GLP-1 Market
Seeking Alpha
Friday, June 28, 2013 - 10:13am
tags:
Novo Nordisk, diabetes, Eli Lilly, GLP-1 agonist, AstraZeneca, Bristol-Myers Squibb, dulaglutide, Victoza
Bayer says FDA requests more data on Xarelto for stent patients
Reuters
Friday, June 28, 2013 - 10:11am
tags:
Bayer, FDA, Xarelto, bloodthinners, stents
FDA approves new Baxter drug for hemophilia B
Reuters
Thursday, June 27, 2013 - 9:01pm
tags:
hemophilia B, Baxter International, Rixubis, FDA
Game may not be over for Royalty' Pharma's bid for Elan
Reuters
Thursday, June 27, 2013 - 8:59pm
tags:
M&A, Elan, Royalty Pharma, Mylan, Allergan, Endo Health Solutions, Forest Labs
SAS And GSK Pull Big Pharma Into Big Data Collaboration
Forbes
Thursday, June 27, 2013 - 8:57pm
tags:
SAS, GSK, data
Is This What the Doctor Ordered for Eli Lilly?
Motley Fool
Thursday, June 27, 2013 - 8:55pm
tags:
Eli Lilly, diabetes, dulaglutide, JNJ, Merck, Novo Nordisk, Bristol-Myers Squibb
IPO Preview: Prosensa Holding B.V.
Seeking Alpha
Thursday, June 27, 2013 - 8:53pm
tags:
IPOs, Prosensa, GSK
Novel Heart Failure Drug From Novartis Gains 'Breakthrough Therapy' Designation From FDA
Forbes
Thursday, June 27, 2013 - 8:52pm
tags:
breakthrough therapies, heart failure, Novatis, serelaxin
J&J's pharma chairman lands 'more deals' in Boston innovation push
Fierce Biotech
Thursday, June 27, 2013 - 11:58am
tags:
JNJ, Boston, innovation, Rodin Therapeutics, Vedanta Biosciences
Glaxo grabs coveted breakthrough drug status for muscular dystrophy drug
Fierce Biotech
Thursday, June 27, 2013 - 11:56am
tags:
breakthrough therapies, GSK, drisapersen, Duchenne Muscular Dystrophy
Sanofi, Novartis, GlaxoSmithKline reportedly circling India's Elder Pharma
Fierce Pharma
Thursday, June 27, 2013 - 11:51am
tags:
India, Sanofi, Novartis, GSK, Elder Pharmaceuticals, M&A
Zogenix and Valeant Pharmaceuticals Enter Exclusive Co-Promotion Agreement for Migranal(R) Nasal Spray
Yahoo
Thursday, June 27, 2013 - 11:49am
tags:
Zogenix, Valeant Pharmaceuticals, Migranal, migraines
Novel Vaccine Fights Type 1 Diabetes in Mid-Stage Study
Bloomberg
Thursday, June 27, 2013 - 11:44am
tags:
type 1 diabetes, vaccines, TOL-3021, Tolerion
Novo Nordisk Suspends Paula Deen As A Spokesperson
Pharmalot
Thursday, June 27, 2013 - 11:15am
tags:
Novo Nordisk, Paula Deen, diabetes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.